Hexstone Capital Files Schedule 13G for Actuate Therapeutics
Hexstone Capital LLC filed a Schedule 13G for Actuate Therapeutics. The filing date is shown as October 30, 20.
Hexstone Capital LLC filed a Schedule 13G for Actuate Therapeutics. The filing date is shown as October 30, 20.